Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

Tomita, Y; Fukasawa, S; Shinohara, N; Kitamura, H; Oya, M; Eto, M; Tanabe, K; Saito, M; Kimura, G; Yonese, J; Yao, M; Uemura, H

Tomita, Y (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Urol, Mol Oncol, Asahimachi 1-757, Niigata 9518510, Japan.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019; 49 (6): 506

Abstract

Efficacy and safety results of CheckMate 025 were consistent between the global and the Japanese populations, with a notably higher OS and ORR in Japa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索